3-D Matrix, Ltd. (TYO:7777)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	25,824	13,897	9,522	9,967	18,944	11,335
Market Cap Growth	45.95%	45.95%	-4.46%	-47.39%	67.12%	-5.42%
Enterprise Value	27,184	15,112	12,421	12,632	19,037	11,484
Last Close Price	230.00	126.00	120.00	157.00	346.00	259.00
PS Ratio	3.72	2.00	2.08	4.31	12.58	11.07
PB Ratio	11.66	6.27	26.98	19.02	12.99	6.83
P/TBV Ratio	11.66	6.27	26.98	19.02	12.99	6.83
PEG Ratio	-	4.10	4.10	4.10	4.10	4.10
EV/Sales Ratio	3.92	2.18	2.71	5.46	12.64	11.22
Debt / Equity Ratio	1.33	1.33	11.82	8.35	2.51	0.88
Asset Turnover	1.12	1.12	0.78	0.41	0.33	0.31
Inventory Turnover	0.94	0.94	0.51	0.43	0.50	0.46
Quick Ratio	2.22	2.22	1.65	1.37	3.77	1.66
Current Ratio	4.07	4.07	3.77	4.35	6.43	4.50
Return on Equity (ROE)	-194.78%	-194.78%	-58.15%	-246.72%	-121.49%	-188.65%
Return on Assets (ROA)	-11.65%	-11.65%	-22.60%	-34.52%	-37.51%	-50.00%
Return on Capital (ROIC)	-14.93%	-14.93%	-28.08%	-39.40%	-41.50%	-61.43%
Earnings Yield	-9.68%	-18.00%	-2.68%	-24.53%	-10.00%	-17.75%
FCF Yield	-6.68%	-12.42%	-19.95%	-46.16%	-15.36%	-28.82%
Buyback Yield / Dilution	-35.41%	-35.41%	-21.76%	-18.18%	-25.66%	-35.32%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.